Next 10 |
home / stock / cmps / cmps articles
As the Benzinga Cannabis Capital Conference gets underway in Florida, gathering top CEOs, investors and leaders in the cannabis industry, let'...
LONDON, April 01, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (NASDAQ:CMPS), a biotechnology company dedicated to accelerating patient access ...
U.S. stocks were lower, with the Dow Jones falling around 250 points on Monday. Shares of Micron Technology, Inc. (NASDAQ: MU) rose sharply during ...
LONDON, March 28, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (NASDAQ:CMPS) ("Compass"), a biotechnology company dedicated to accelerating pat...
Mind Medicine (MindMed) (NASDAQ:MNMD) announced that the FDA has granted the "breakthrough therapy" designation to its MM120 (lysergide d-tartrate)...
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter fin...
Welcome to a new episode of our Benzinga Psychedelics Podcast, this time joined by business trendspotter and "psychedelics concierge" Zappy Zapolin...
LONDON, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (NASDAQ:CMPS), a biotechnology company dedicated to accelerating patient access t...
LONDON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (NASDAQ:CMPS), a biotechnology company dedicated to accelerating patient access t...
News, Short Squeeze, Breakout and More Instantly...
COMPASS Pathways Plc Company Name:
CMPS Stock Symbol:
NASDAQ Market:
Ayahuasca is a psychoactive brew that has been used for centuries by Indigenous cultures in South America for divination, spiritual ceremonies and healing. It is made from the Psychotria viridis shrub and the Banisteriopsis caapi vine, which contain DMT and harmala alkaloids, respectively. Int...
As the Benzinga Cannabis Capital Conference gets underway in Florida, gathering top CEOs, investors and leaders in the cannabis industry, let'...
Diabetes is a chronic illness characterized by high levels of blood sugar. There are different types of diabetes, the most common being types I and II. Latest data estimates that by 2045, more than 700 million individuals globally could be afflicted with the illness as its prevalence continued...